Laborie Medical Technologies
Nov 02, 2023
Laborie Medical Acquired Urotronic; Sirtex’s LAVA Liquid Embolic System; Paige’s Cancer Detection in Breast Lymph Nodes; FDA Clearance to Neurovalens’s Non-Invasive Insomnia-Treating Device; Recor Medical’s Renal Denervation System; Pulsecare Medical’s nsPFA Clinical Trial Short-term Follow-up Results
Neurovalens Received US FDA Clearance for Non-Invasive Insomnia-Treating Device On October 30, 2023, Belfast, Northern Ireland-based Neurovalens announced the US Food and Drug Administration clearance for its Modius Sleep device meant for treating chronic insomnia. Modius has been designed to deli...
Read More...
Sep 07, 2023
Boston Scientific’s WATCHMAN FLX™ Pro; Quest Diagnostics’s AAV Test; Vitestro Started A.D.O.P.T. Clinical Trial; Signia Introduces Hearing Aids; Laborie Medical to Acquire Urotronic; Synchron’s Brain-Computer Interface Trial
Quest Diagnostics Granted FDA Breakthrough Designation for its Adeno-associated virus (AAV) Test On August 30, 2023, Quest Diagnostics announced that its AAVrh74 ELISA assay (CDx) has been granted Breakthrough Device Designation from the US Food and Drug Administration (FDA). The enzyme-linked immunosor...
Read More...
Apr 06, 2023
Laborie Launched alpHaONE; Cadwell Launched Arc Voyager; Endotronix’s PROACTIVE-HF Pivotal Trial; Sonex Health’s Office-based Carpal Tunnel Release System with Ultrasound Guidance; Leica Biosystems’s BOND MMR Antibody Panel; Abbott Received FDA Approval for Epic™ Max Tissue Valve
Sonex Health Announced US Clinical Study to Report Safety and Effectiveness of Office-based Carpal Tunnel Release System with Ultrasound Guidance On March 30 2023, Sonex Health, Inc., a leader in innovative ultrasound guided therapies to treat common orthopaedic conditions and The Institute of Advanced Ult...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
